Non-enzymatic role of SOD1 in intestinal stem cell growth

Abstract Superoxide dismutase 1 (SOD1) modulates intestinal barrier integrity and intestinal homeostasis as an antioxidant enzyme. Intestinal homeostasis is maintained by the intestinal stem cells (ISCs). However, whether and how SOD1 regulates ISCs is unknown. In this study, we established intestin...

Full description

Bibliographic Details
Main Authors: Ying-Chao Wang, Xiao-Xu Leng, Cheng-Bei Zhou, Shi-Yuan Lu, Chi Kwan Tsang, Jie Xu, Ming-Ming Zhang, Hui-Min Chen, Jing-Yuan Fang
Format: Article
Language:English
Published: Nature Publishing Group 2022-10-01
Series:Cell Death and Disease
Online Access:https://doi.org/10.1038/s41419-022-05267-w
_version_ 1811336440933515264
author Ying-Chao Wang
Xiao-Xu Leng
Cheng-Bei Zhou
Shi-Yuan Lu
Chi Kwan Tsang
Jie Xu
Ming-Ming Zhang
Hui-Min Chen
Jing-Yuan Fang
author_facet Ying-Chao Wang
Xiao-Xu Leng
Cheng-Bei Zhou
Shi-Yuan Lu
Chi Kwan Tsang
Jie Xu
Ming-Ming Zhang
Hui-Min Chen
Jing-Yuan Fang
author_sort Ying-Chao Wang
collection DOAJ
description Abstract Superoxide dismutase 1 (SOD1) modulates intestinal barrier integrity and intestinal homeostasis as an antioxidant enzyme. Intestinal homeostasis is maintained by the intestinal stem cells (ISCs). However, whether and how SOD1 regulates ISCs is unknown. In this study, we established intestinal organoids from tamoxifen–inducible intestinal epithelial cell–specific Sod1 knockout (Sod1 f/f ; Vil-creERT2) mice. We found that loss of Sod1 in organoids suppressed the proliferation and survival of cells and Lgr5 gene expression. SOD1 is known for nearly half a century for its canonical role as an antioxidant enzyme. We identified its enzyme-independent function in ISC: inhibition of SOD1 enzymatic activity had no impact on organoid growth, and enzymatically inactive Sod1 mutants could completely rescue the growth defects of Sod1 deficient organoids, suggesting that SOD1-mediated ISC growth is independent of its enzymatic activity. Moreover, Sod1 deficiency did not affect the ROS levels of the organoid, but induced the elevated WNT signaling and excessive Paneth cell differentiation, which mediates the occurrence of growth defects in Sod1 deficient organoids. In vivo, epithelial Sod1 loss induced a higher incidence of apoptosis in the stem cell regions and increased Paneth cell numbers, accompanied by enhanced expression of EGFR ligand Epiregulin (EREG) in the stromal tissue, which may compensate for Sod1 loss and maintain intestinal structure in vivo. Totally, our results show a novel enzyme-independent function of SOD1 in ISC growth under homeostasis.
first_indexed 2024-04-13T17:39:30Z
format Article
id doaj.art-3dab9c9d621a4a2997306fc5d81240e3
institution Directory Open Access Journal
issn 2041-4889
language English
last_indexed 2024-04-13T17:39:30Z
publishDate 2022-10-01
publisher Nature Publishing Group
record_format Article
series Cell Death and Disease
spelling doaj.art-3dab9c9d621a4a2997306fc5d81240e32022-12-22T02:37:13ZengNature Publishing GroupCell Death and Disease2041-48892022-10-01131011310.1038/s41419-022-05267-wNon-enzymatic role of SOD1 in intestinal stem cell growthYing-Chao Wang0Xiao-Xu Leng1Cheng-Bei Zhou2Shi-Yuan Lu3Chi Kwan Tsang4Jie Xu5Ming-Ming Zhang6Hui-Min Chen7Jing-Yuan Fang8Division of Gastroenterology and Hepatology; Shanghai Institute of Digestive Disease; NHC Key Laboratory of Digestive Diseases; State Key Laboratory for Oncogenes and Related Genes; Renji Hospital, School of Medicine, Shanghai Jiao Tong UniversityDivision of Gastroenterology and Hepatology; Shanghai Institute of Digestive Disease; NHC Key Laboratory of Digestive Diseases; State Key Laboratory for Oncogenes and Related Genes; Renji Hospital, School of Medicine, Shanghai Jiao Tong UniversityDivision of Gastroenterology and Hepatology; Shanghai Institute of Digestive Disease; NHC Key Laboratory of Digestive Diseases; State Key Laboratory for Oncogenes and Related Genes; Renji Hospital, School of Medicine, Shanghai Jiao Tong UniversityDivision of Gastroenterology and Hepatology; Shanghai Institute of Digestive Disease; NHC Key Laboratory of Digestive Diseases; State Key Laboratory for Oncogenes and Related Genes; Renji Hospital, School of Medicine, Shanghai Jiao Tong UniversityClinical Neuroscience Institute, The First Affiliated Hospital of Jinan UniversityInstitutes of Biomedical Sciences, Zhongshan-Xuhui Hospital, Fudan UniversityDivision of Gastroenterology and Hepatology; Shanghai Institute of Digestive Disease; NHC Key Laboratory of Digestive Diseases; State Key Laboratory for Oncogenes and Related Genes; Renji Hospital, School of Medicine, Shanghai Jiao Tong UniversityDivision of Gastroenterology and Hepatology; Shanghai Institute of Digestive Disease; NHC Key Laboratory of Digestive Diseases; State Key Laboratory for Oncogenes and Related Genes; Renji Hospital, School of Medicine, Shanghai Jiao Tong UniversityDivision of Gastroenterology and Hepatology; Shanghai Institute of Digestive Disease; NHC Key Laboratory of Digestive Diseases; State Key Laboratory for Oncogenes and Related Genes; Renji Hospital, School of Medicine, Shanghai Jiao Tong UniversityAbstract Superoxide dismutase 1 (SOD1) modulates intestinal barrier integrity and intestinal homeostasis as an antioxidant enzyme. Intestinal homeostasis is maintained by the intestinal stem cells (ISCs). However, whether and how SOD1 regulates ISCs is unknown. In this study, we established intestinal organoids from tamoxifen–inducible intestinal epithelial cell–specific Sod1 knockout (Sod1 f/f ; Vil-creERT2) mice. We found that loss of Sod1 in organoids suppressed the proliferation and survival of cells and Lgr5 gene expression. SOD1 is known for nearly half a century for its canonical role as an antioxidant enzyme. We identified its enzyme-independent function in ISC: inhibition of SOD1 enzymatic activity had no impact on organoid growth, and enzymatically inactive Sod1 mutants could completely rescue the growth defects of Sod1 deficient organoids, suggesting that SOD1-mediated ISC growth is independent of its enzymatic activity. Moreover, Sod1 deficiency did not affect the ROS levels of the organoid, but induced the elevated WNT signaling and excessive Paneth cell differentiation, which mediates the occurrence of growth defects in Sod1 deficient organoids. In vivo, epithelial Sod1 loss induced a higher incidence of apoptosis in the stem cell regions and increased Paneth cell numbers, accompanied by enhanced expression of EGFR ligand Epiregulin (EREG) in the stromal tissue, which may compensate for Sod1 loss and maintain intestinal structure in vivo. Totally, our results show a novel enzyme-independent function of SOD1 in ISC growth under homeostasis.https://doi.org/10.1038/s41419-022-05267-w
spellingShingle Ying-Chao Wang
Xiao-Xu Leng
Cheng-Bei Zhou
Shi-Yuan Lu
Chi Kwan Tsang
Jie Xu
Ming-Ming Zhang
Hui-Min Chen
Jing-Yuan Fang
Non-enzymatic role of SOD1 in intestinal stem cell growth
Cell Death and Disease
title Non-enzymatic role of SOD1 in intestinal stem cell growth
title_full Non-enzymatic role of SOD1 in intestinal stem cell growth
title_fullStr Non-enzymatic role of SOD1 in intestinal stem cell growth
title_full_unstemmed Non-enzymatic role of SOD1 in intestinal stem cell growth
title_short Non-enzymatic role of SOD1 in intestinal stem cell growth
title_sort non enzymatic role of sod1 in intestinal stem cell growth
url https://doi.org/10.1038/s41419-022-05267-w
work_keys_str_mv AT yingchaowang nonenzymaticroleofsod1inintestinalstemcellgrowth
AT xiaoxuleng nonenzymaticroleofsod1inintestinalstemcellgrowth
AT chengbeizhou nonenzymaticroleofsod1inintestinalstemcellgrowth
AT shiyuanlu nonenzymaticroleofsod1inintestinalstemcellgrowth
AT chikwantsang nonenzymaticroleofsod1inintestinalstemcellgrowth
AT jiexu nonenzymaticroleofsod1inintestinalstemcellgrowth
AT mingmingzhang nonenzymaticroleofsod1inintestinalstemcellgrowth
AT huiminchen nonenzymaticroleofsod1inintestinalstemcellgrowth
AT jingyuanfang nonenzymaticroleofsod1inintestinalstemcellgrowth